Data Access For Informed Patient Stratification

Successful clinical trials depend on better-informed patient stratification strategies. These strategies can be fraught with inefficiencies due to:

• Data access
• Ad hoc querying
• Data aggregation
• Repeatable analytics for cross-study biomarker analysis

Leveraging best-in-class data analytics technologies, PerkinElmer Signals Translational Enterprise is designed to address those inefficiencies and improve clinical trial development and design process, with user-friendly applications and self-service access to data for biomarker discovery and patient stratification cohorts across large and diverse datasets.